Home › Funds › Millennium Management › BCRX
Millennium Management position in BCRX
BIOCRYST PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)3.39M sh
Reported value held$33.95M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 421.85K | $6.06M | New |
| Q4 2021 | 115.83K | $1.60M | Reduce |
| Q1 2022 | 54.95K | $894.00K | Reduce |
| Q2 2022 | 1.95M | $20.62M | Add |
| Q3 2022 | 1.33M | $16.71M | Reduce |
| Q4 2022 | 116.49K | $1.34K | Reduce |
| Q1 2023 | 4.73M | $39.48K | Add |
| Q2 2023 | 5.40M | $38.04M | Add |
| Q3 2023 | 5.13M | $36.34M | Reduce |
| Q4 2023 | 2.27M | $13.59M | Reduce |
| Q1 2024 | 2.03M | $10.32M | Reduce |
| Q2 2024 | 1.75M | $10.82M | Reduce |
| Q3 2024 | 1.42M | $10.82M | Reduce |
| Q4 2024 | 790.11K | $5.94M | Reduce |
| Q1 2025 | 3.81M | $28.60M | Add |
| Q2 2025 | 2.01M | $17.98M | Reduce |
| Q3 2025 | 460.95K | $3.50M | Reduce |
| Q4 2025 | 137.63K | $1.07M | Reduce |
| Q1 2026 | 317.72K | $3.02M | Add |
| Q2 2026 | 3.39M | $33.95M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BCRX
- BlackRock Inc 23.89M sh · $238.93M · Q2 2026
- Vanguard Group 22.27M sh · $173.73M · Q4 2025
- Janus Henderson Group 8.91M sh · $84.85M · Q1 2026
- Two Sigma Investments 6.78M sh · $67.75M · Q2 2026
- Geode Capital Management 6.25M sh · $62.49M · Q2 2026
- UBS Group AG 5.08M sh · $50.78M · Q2 2026
- Bank of America Corp 4.80M sh · $48.01M · Q2 2026
- Goldman Sachs Group 4.48M sh · $44.82M · Q2 2026
- Renaissance Technologies 2.53M sh · $25.30M · Q2 2026
- Charles Schwab Investment Management 2.35M sh · $23.53M · Q2 2026
- Northern Trust Corp 2.26M sh · $22.56M · Q2 2026